Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial.

Autor: Asensi-Cantó A; Facultad de Ciencias de la Salud, Universidad Católica de Murcia (UCAM), Guadalupe, Spain.; Pharmacy Department, Hospital Universitario Santa Lucía, Cartagena, Spain.; Molecular Pathology and Pharmacogenetics Research Group, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Universitario Santa Lucía, Cartagena, Spain., Rodríguez-Braun E; Oncology Department, Hospital Universitario Santa Lucía, Cartagena, Spain., Beltrán-Videla A; Molecular Pathology and Pharmacogenetics Research Group, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Universitario Santa Lucía, Cartagena, Spain., Hurtado AM; Molecular Pathology and Pharmacogenetics Research Group, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Universitario Santa Lucía, Cartagena, Spain.; Innmunobiology for Aquaculture Research Group, Cellular Biology and Histology Department, Universidad de Murcia, Murcia, Spain., Conesa-Zamora P; Molecular Pathology and Pharmacogenetics Research Group, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Universitario Santa Lucía, Cartagena, Spain.; Laboratory Medicine Department, Hospital Universitario Santa Lucía, Cartagena, Spain.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Sep 29; Vol. 13, pp. 1238464. Date of Electronic Publication: 2023 Sep 29 (Print Publication: 2023).

The treatment of advanced gastric cancer: current strategies and future perspectives

Autor: Cervantes, A., Roselló, S., Roda, D., Rodríguez-Braun, E.

Publikováno v: In Annals of Oncology July 2008 19 Supplement 5:v103-v107

Global Methylome Scores Correlate with Histological Subtypes of Colorectal Carcinoma and Show Different Associations with Common Clinical and Molecular Features.

Autor: Turpín-Sevilla MDC; Facultad de Medicina, Universidad Francisco de Vitoria, Ctra. Pozuelo-Majadahonda, Km 1800, Pozuelo de Alarcón, 28223 Madrid, Spain., Pérez-Sanz F; Biomedical Informatics & Bioinformatics Platform, Institute for Biomedical Research of Murcia (IMIB)/Foundation for Healthcare Training & Research of the Region of Murcia (FFIS), Calle Luis Fontes Pagán 9, 30003 Murcia, Spain., García-Solano J; Department of Pathology, Santa Lucía General University Hospital (HGUSL), C/Mezquita s/n, 30202 Cartagena, Spain.; Facultad de Ciencias de la Salud, Universidad Católica de Murcia (UCAM), Campus Los Jerónimos, 30107 Guadalupe, Spain.; Group of Molecular Pathology and Pharmacogenetics, Institute for Biomedical Research from Murcia (IMIB), HGUSL, 30202 Cartagena, Spain., Sebastián-León P; IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain., Trujillo-Santos J; Department of Internal Medicine, Santa Lucía General University Hospital (HGUSL), C/Mezquita s/n, 30202 Cartagena, Spain., Carbonell P; Biochemistry and Clinical Genetic Center, Virgen de la Arrixaca University Hospital, 30100 Murcia, Spain., Estrada E; Department of Social Psychology and Methodology, Universidad Autónoma de Madrid, 28049 Madrid, Spain., Tuomisto A; Cancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland., Herruzo I; Facultad de Medicina, Universidad Francisco de Vitoria, Ctra. Pozuelo-Majadahonda, Km 1800, Pozuelo de Alarcón, 28223 Madrid, Spain., Fennell LJ; QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.; Conjoint Internal Medicine Laboratory, Pathology Queensland, Herston, QLD 4006, Australia.; Faculty of Medicine, The University of Queensland, Herston, QLD 4072, Australia., Mäkinen MJ; Cancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland., Rodríguez-Braun E; Clinical Oncology Department, Santa Lucía General University Hospital (HGUSL). C/Mezquita s/n, 30202 Cartagena, Spain., Whitehall VLJ; QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.; Conjoint Internal Medicine Laboratory, Pathology Queensland, Herston, QLD 4006, Australia.; Faculty of Medicine, The University of Queensland, Herston, QLD 4072, Australia., Conesa A; Microbiology and Cell Sciences Department, Institute for Food and Agricultural Sciences, Genetics Institute, University of Florida, Gainesville, FL 32611, USA., Conesa-Zamora P; Facultad de Ciencias de la Salud, Universidad Católica de Murcia (UCAM), Campus Los Jerónimos, 30107 Guadalupe, Spain.; Group of Molecular Pathology and Pharmacogenetics, Institute for Biomedical Research from Murcia (IMIB), HGUSL, 30202 Cartagena, Spain.; Clinical Oncology Department, Santa Lucía General University Hospital (HGUSL). C/Mezquita s/n, 30202 Cartagena, Spain.; Department of Clinical Analysis, Santa Lucía General University Hospital (HGUSL), C/Mezquita s/n, 30202 Cartagena, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2021 Oct 14; Vol. 13 (20). Date of Electronic Publication: 2021 Oct 14.

946P - Predictive and prognostic value of tumor cells and circulating plasma free DNA in advanced epithelial ovarian carcinoma

Autor: Martinez-Garcia, J., Minguela Puras, A., Cascales Campos, P.A., Martinez Sanchez, M.V., Gil Martinez, J., Barcelo Valcarcel, F., Rodriguez Hernandez, J.R., Torroba Caron, M.A., Soto-Gutierrez, A., Sanchez Henarejos, P., Puertes Boix, A., Montenegro Luis, S., Ruiz Carreño, P., Rodriguez Braun, E., Jimenez Lucas, M.D., Guirao Marín, M., Cuellar Rivas, M.A., Cano Jimenez, A., Anton Garcia, A., Alonso Romero, J.L.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v336-v336

Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.

Autor: Martín-Martorell, P., Roselló, S., Rodríguez-Braun, E., Chirivella, I., Bosch, A., Cervantes, A., Martín-Martorell, P, Roselló, S, Rodríguez-Braun, E

Publikováno v: British Journal of Cancer; 8/5/2008, Vol. 99 Issue 3, p455-458, 4p, 3 Charts, 2 Graphs